{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/breast-cancer-peer-reviewed-journal-articles-featuring-fortrea-oncologists#webpage",
"url": "https://www.fortrea.com/insights/breast-cancer-peer-reviewed-journal-articles-featuring-fortrea-oncologists",
"name": "Breast cancer: Peer-reviewed journal articles featuring Fortrea oncologists",
"description": "This Fortrea info sheet highlights peer-reviewed breast cancer clinical research and scientific publications from Fortrea oncologists focused on emerging oncology therapies and precision medicine strategies. The publication features scientific insights related to targeted breast cancer therapies, biomarker-driven oncology research, precision oncology approaches, and evolving treatment strategies within oncology clinical development activities. The featured research discusses emerging therapeutic approaches, translational oncology research, combination treatment strategies, and scientific advancements supporting modern breast cancer treatment development. The publication also highlights collaborative oncology research contributions supporting scientific understanding of targeted therapies and precision oncology applications across breast cancer clinical research. By contributing to peer-reviewed scientific publications and breast cancer oncology research, Fortrea oncology specialists support continued advancement in precision oncology and emerging cancer treatment strategies."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Breast cancer: Peer-reviewed journal articles featuring Fortrea oncologists",
"item": "https://www.fortrea.com/insights/breast-cancer-peer-reviewed-journal-articles-featuring-fortrea-oncologists"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/breast-cancer-peer-reviewed-journal-articles-featuring-fortrea-oncologists#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/breast-cancer-peer-reviewed-journal-articles-featuring-fortrea-oncologists#webpage"
},
"headline": "Breast cancer: Peer-reviewed journal articles featuring Fortrea oncologists",
"description": "This Fortrea info sheet highlights peer-reviewed breast cancer clinical research and scientific publications from Fortrea oncologists focused on emerging oncology therapies and precision medicine strategies. The publication features scientific insights related to targeted breast cancer therapies, biomarker-driven oncology research, precision oncology approaches, and evolving treatment strategies within oncology clinical development activities. The featured research discusses emerging therapeutic approaches, translational oncology research, combination treatment strategies, and scientific advancements supporting modern breast cancer treatment development. The publication also highlights collaborative oncology research contributions supporting scientific understanding of targeted therapies and precision oncology applications across breast cancer clinical research. By contributing to peer-reviewed scientific publications and breast cancer oncology research, Fortrea oncology specialists support continued advancement in precision oncology and emerging cancer treatment strategies.",
"genre": "Info Sheet",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-07-11",
"dateModified": "2025-07-11",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-04/breast-cancer-peer-reviewed-articles-fortrea-oncologists-10-04-2026.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/breast-cancer-peer-reviewed-journal-articles-featuring-fortrea-oncologists#webpage",
"url": "https://www.fortrea.com/insights/breast-cancer-peer-reviewed-journal-articles-featuring-fortrea-oncologists",
"name": "Breast cancer: Peer-reviewed journal articles featuring Fortrea oncologists",
"description": "This Fortrea info sheet highlights peer-reviewed breast cancer clinical research and scientific publications from Fortrea oncologists focused on emerging oncology therapies and precision medicine strategies. The publication features scientific insights related to targeted breast cancer therapies, biomarker-driven oncology research, precision oncology approaches, and evolving treatment strategies within oncology clinical development activities. The featured research discusses emerging therapeutic approaches, translational oncology research, combination treatment strategies, and scientific advancements supporting modern breast cancer treatment development. The publication also highlights collaborative oncology research contributions supporting scientific understanding of targeted therapies and precision oncology applications across breast cancer clinical research. By contributing to peer-reviewed scientific publications and breast cancer oncology research, Fortrea oncology specialists support continued advancement in precision oncology and emerging cancer treatment strategies."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Breast cancer: Peer-reviewed journal articles featuring Fortrea oncologists",
"item": "https://www.fortrea.com/insights/breast-cancer-peer-reviewed-journal-articles-featuring-fortrea-oncologists"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/breast-cancer-peer-reviewed-journal-articles-featuring-fortrea-oncologists#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/breast-cancer-peer-reviewed-journal-articles-featuring-fortrea-oncologists#webpage"
},
"headline": "Breast cancer: Peer-reviewed journal articles featuring Fortrea oncologists",
"description": "This Fortrea info sheet highlights peer-reviewed breast cancer clinical research and scientific publications from Fortrea oncologists focused on emerging oncology therapies and precision medicine strategies. The publication features scientific insights related to targeted breast cancer therapies, biomarker-driven oncology research, precision oncology approaches, and evolving treatment strategies within oncology clinical development activities. The featured research discusses emerging therapeutic approaches, translational oncology research, combination treatment strategies, and scientific advancements supporting modern breast cancer treatment development. The publication also highlights collaborative oncology research contributions supporting scientific understanding of targeted therapies and precision oncology applications across breast cancer clinical research. By contributing to peer-reviewed scientific publications and breast cancer oncology research, Fortrea oncology specialists support continued advancement in precision oncology and emerging cancer treatment strategies.",
"genre": "Info Sheet",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-07-11",
"dateModified": "2025-07-11",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-04/breast-cancer-peer-reviewed-articles-fortrea-oncologists-10-04-2026.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
Info Sheet